CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Add on effect of dhūpana with jaṬādi varti in positive symptoms of schizophrenia - a single group clinical trial (ab design)

Author: 
Dr. Aswani, PK., Dr. Jayadevan, C.V. and Dr. Satheesh, K.
Subject Area: 
Health Sciences
Abstract: 

Introduction: Schizophrenia is one of the most debilitating, complex and chronic psychiatric disorders which disrupt a person’s ability to think, feel and act. It is characterized by delusions, hallucinations, disorganized behaviour, grossly disorganized or catatonic behaviour and negative symptoms. Among this delusions, hallucinations, disorganized behaviour and grossly disorganized or catatonic behaviour can be called as positive symptoms of schizophrenia. Most of the symptoms of schizophrenia found similar to the symptoms of unmāda-a disease explained in Ayurveda classics. So schizophrenia can be correlated with unmāda and its management is being used with efficacy in such cases. A management protocol with ṡodhana (elimination therapy), ṡamana (palliative therapy) followed by rasāyana (rejuvenation therapy) and satvāvajaya, distinct psycho educative approach is being in use for schizophrenia. Dhūpana (fumigation therapy) is one of the techniques mainly used in the management of psychotic conditions along with ṡodhana and ṡamana. Jaṭādi varti dhūpana which is being practicing for the last 10 years has taken as trial drug for its efficacy in the positive symptoms of schizophrenia. Methodology: 28 subjects satisfying the inclusion criteria were selected from OPD of Vaidyaratnam PS Varier Ayurveda College and Government Ayurveda Research Institute for Mental diseases (GARIM), Kottakkal and those who were taking antipsychotics and had no improvements were considered as phase A and observed for 2 weeks and then they were administered jaṭādi varti dhūpana as phase B for 15 minutes twice daily for a period of 7 days. Assessments were done using Scale for Assessment for Positive Symptoms of Schizophrenia (SAPS) and WHO Quality Of Life BREF questionnaire on 0th, 14th, 18th, 21st and 28th day. Results: On assessment, most of the domains were statistically significant at the level of p <.05. The study concluded that administration of jaṭādi varti dhūpana has got significant effect in reducing the positive symptoms of schizophrenia and also in the quality of life.

PDF file: 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran